Hillsdale Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.8M | Buy |
536,000
+13,700
| +3% | +$123K | 0.18% | 176 |
|
|
2025
Q1 | $3.92M | Sell |
522,300
-19,800
| -4% | -$149K | 0.2% | 117 |
|
|
2024
Q4 | $4.08M | Buy |
542,100
+541,270
| +65,213% | +$4.07M | 0.21% | 129 |
|
|
2024
Q3 | $6.31K | Buy |
+830
| New | +$6.31K | ﹤0.01% | 561 |
|
|
2020
Q3 | – | Sell |
-172,000
| Closed | -$820K | – | 579 |
|
|
2020
Q2 | $820K | Buy |
+172,000
| New | +$820K | 0.07% | 206 |
|